Finnrick, an independent testing programme, publishes 59 assays for Xingtai Jiachuang Technology: 41 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 18 did not. Most recent assay 3 Aug 2026.
Xingtai Jiachuang Technology operates from China, listed by Finnrick as "Trading", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/xingtai-jiachuang-technology.
Finnrick-tested with poor results. Tested across 3 peptide products with 41 total samples.
Xingtai Jiachuang Technology is listed as active. Finnrick Grade D. Finnrick avg score: 6.8/10 across 41 samples (3 products). Below-average quality. Exercise caution.
Xingtai Jiachuang Technology holds independent lab grade D, assigned across 41 graded samples, average score 6.8/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 28 | 21 passed, 7 failed |
| Retatrutide | 16 | 12 passed, 4 failed |
| Tesamorelin | 10 | 3 passed, 7 failed |
| GHK-Cu | 5 | 5 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | D (41 samples) |
| Average grader score | 6.8/10 |
| Vendor type | Research-use supplier |
These details were read from Xingtai Jiachuang Technology's own website on 2026-08-17. Pages consulted:
Xingtai Jiachuang Technology is listed as active and we hold 59 Finnrick assays (41 passing, 18 failing its purity threshold); an independent lab grade of D. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 59 assays for Xingtai Jiachuang Technology: 41 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 18 did not. Most recent assay 3 Aug 2026.
Similar vendors: SwissChems, Bfflink, Reta-Peptide, HkRoids, Zenith Jove Peptide ZJ, Shanghai Baoju, Heman Peptide HM, Allen Biotechnology Co ABC.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Xingtai Lesda Technology Peptides Review, Xingtai Pukelai Technology Co Peptides Review, Xingtai Yingpeptide Technology Review.